Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Pasquali

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Journal of the National Cancer Institute|February 25, 2010
Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysisSimone Mocellin, Sandro Pasquali, Carlo R Rossi, et al.
Surgery|June 21, 2011
Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 casesSimone Mocellin, Sandro Pasquali, Carlo Riccardo Rossi, et al.
World Journal of Surgery|April 27, 2017
Effectiveness of Antibiotic Prophylaxis in Non-emergency Cholecystectomy Using Data from a Population-Based Cohort StudyRavinder S Vohra, James Hodson, Sandro Pasquali, et al.
Cancer Treatment Reviews|February 13, 2017
Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: A network meta-analysisSandro Pasquali, Vanna Chiarion-Sileni, Carlo Riccardo Rossi, et al.
Current Opinion in Oncology|May 10, 2024
New targeted therapies in liposarcoma: state of art and future perspectivesAndrea Franza, Chiara Fabbroni, Sandro Pasquali, et al.
Annals of Surgical Oncology|November 8, 2007
N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanomaCarlo Riccardo Rossi, Simone Mocellin, Sandro Pasquali, et al.
Annals of Surgical Oncology|September 21, 2013
Patterns of recurrence and survival after lymphadenectomy in melanoma patients: clarifying the effects of timing of surgery and lymph node tumor burdenAndrew J Spillane, Sandro Pasquali, Lauren E Haydu, et al.
Current Opinion in Oncology|April 21, 2017
Neoadjuvant treatment: a novel standard?Sandro Pasquali, Elena Palassini, Silvia Stacchiotti, et al.
Annals of Surgical Oncology|February 11, 2015
Outcomes Following Extended Surgery for Retroperitoneal Sarcomas: Results From a UK Referral CentreSandro Pasquali, Ravinder Vohra, Ioanna Tsimopoulou, et al.
The Cochrane Database of Systematic Reviews|June 19, 2013
Interferon alpha for the adjuvant treatment of cutaneous melanomaSimone Mocellin, Marko B Lens, Sandro Pasquali, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Journal of the National Cancer Institute|February 25, 2010
Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysisSimone Mocellin, Sandro Pasquali, Carlo R Rossi, et al.
Surgery|June 21, 2011
Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 casesSimone Mocellin, Sandro Pasquali, Carlo Riccardo Rossi, et al.
World Journal of Surgery|April 27, 2017
Effectiveness of Antibiotic Prophylaxis in Non-emergency Cholecystectomy Using Data from a Population-Based Cohort StudyRavinder S Vohra, James Hodson, Sandro Pasquali, et al.
Cancer Treatment Reviews|February 13, 2017
Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: A network meta-analysisSandro Pasquali, Vanna Chiarion-Sileni, Carlo Riccardo Rossi, et al.
Current Opinion in Oncology|May 10, 2024
New targeted therapies in liposarcoma: state of art and future perspectivesAndrea Franza, Chiara Fabbroni, Sandro Pasquali, et al.
Annals of Surgical Oncology|November 8, 2007
N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanomaCarlo Riccardo Rossi, Simone Mocellin, Sandro Pasquali, et al.
Annals of Surgical Oncology|September 21, 2013
Patterns of recurrence and survival after lymphadenectomy in melanoma patients: clarifying the effects of timing of surgery and lymph node tumor burdenAndrew J Spillane, Sandro Pasquali, Lauren E Haydu, et al.
Current Opinion in Oncology|April 21, 2017
Neoadjuvant treatment: a novel standard?Sandro Pasquali, Elena Palassini, Silvia Stacchiotti, et al.
Annals of Surgical Oncology|February 11, 2015
Outcomes Following Extended Surgery for Retroperitoneal Sarcomas: Results From a UK Referral CentreSandro Pasquali, Ravinder Vohra, Ioanna Tsimopoulou, et al.
The Cochrane Database of Systematic Reviews|June 19, 2013
Interferon alpha for the adjuvant treatment of cutaneous melanomaSimone Mocellin, Marko B Lens, Sandro Pasquali, et al.
Pageof 11